Healio ... Clinical Practice,” Nguyen and colleagues evaluated the effectiveness of four oral therapies for HBV in a large, real world-cohort. They found that first-line agents tenofovir and entecavir were more effective than older medications lamivudine and ...
Medscape Antiviral prophylaxis with entecavir might help prevent rituximab-associated hepatitis B virus (HBV) reactivation in patients with lymphoma and resolved hepatitis B, according to a randomized controlled trial. Yi-Hsiang Huang, MD, PhD, from Taipei ...
